Elevated cell invasion in a tumor sphere culture of RSV-M mouse glioma cells

Neurologia Medico-Chirurgica

Volumn 55, Issue 1, 2014, Pages 60-70

  Nonaka, Motonobu ^a   Yawata, Toshio ^a   Takemura, Mitsuhiro ^a   Higashi, Youichirou ^a   Nakai, Eiichi ^a   Shimizu, Keiji ^a   Ueba, Tetsuya ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Glioma; Invasion; Metastatic gene expression; Stem like cells; Tumor sphere

Indexed keywords

FIBRONECTIN; TENASCIN;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; CELL INFILTRATION; CELL MIGRATION; CELL TRANSPLANTATION; COLLAGEN INVASION ASSAY; EXTRACELLULAR MATRIX; FEMALE; GENE; GENE EXPRESSION; GLIOMA CELL LINE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; METASTASIS; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TUMOR CELL CULTURE; TUMOR INVASION; TUMOR METASTASIS RELATED GENE; UPREGULATION; ANIMAL; C3H MOUSE; CELL MOTION; GENE EXPRESSION REGULATION; GLIOMA; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; MICE; MICE, INBRED C3H; NEOPLASM INVASIVENESS;

EID: 84921284081     PISSN: 04708105     EISSN: 13498029     Source Type: Journal    
DOI: 10.2176/nmc.oa.2014-0067     Document Type: Article

References (54)

1. Central Brain Tumor Registry of the United States (CBTRUS): Statistical Report: Primary Brain Tumors in the United States, 1995–1999. CBTRUS, 2002
2. S tupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987–996, 2005
3. Prados MD, Berger MS, Wilson CB: Primary central nervous system tumors: advances in knowledge and treatment. CA Cancer J Clin 48: 331–360, 1998
4. Laws ER, Thapar K: Brain tumors. CA Cancer J Clin 43: 263–271, 1993
5. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, Kornblum HI: Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100: 15178–15183, 2003
6. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821–5828, 2003
7. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F, Vescovi A: Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64: 7011–7021, 2004
8. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB: Identification of human brain tumour initiating cells. Nature 432: 396–401, 2004
9. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756–760, 2006
10. Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB, Shi Q, McLendon RE, Bigner DD, Rich JN: Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66: 7843–7848, 2006
11. Eramo A, Ricci-Vitiani L, Zeuner A, Pallini R, Lotti F, Sette G, Pilozzi E, Larocca LM, Peschle C, De Maria R: Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ 13: 1238–1241, 2006
12. Pellegatta S, Poliani PL, Corno D, Menghi F, Ghielmetti F, Suarez-Merino B, Caldera V, Nava S, Ravanini M, Facchetti F, Bruzzone MG, Finocchiaro G: Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas. Cancer Res 66: 10247–10252, 2006
13. Annabi B, Lachambre MP, Plouffe K, Sartelet H, Béliveau R: Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling. Mol Carcinog 48: 910–919, 2009
14. Annabi B, Rojas-Sutterlin S, Laflamme C, Lachambre MP, Rolland Y, Sartelet H, Béliveau R: Tumor environment dictates medulloblastoma cancer stem cell expression and invasive phenotype. Mol Cancer Res 6: 907–916, 2008
15. Janik P, Szaniawska B, Miloszewska J, Pietruszewska E, Kowalczyk D: The role of protein kinase C in migration of rat glioma cells from spheroid cultures. Cancer Lett 63: 167–170, 1992
16. Engebraaten O, Schwachenwald R, Valen H, Bjerkvig R, Laerum OD, Backlund EO: Effects of high and low single dose irradiation on glioma spheroid invasion into normal rat brain tissue in vitro. Anticancer Res 12: 1501–1506, 1992
17. Pedersen PH, Ness GO, Engebraaten O, Bjerkvig R, Lillehaug JR, Laerum OD: Heterogeneous response to the growth factors [EGF, PDGF (bb), TGF-alpha, bFGF, IL-2] on glioma spheroid growth, migration and invasion. Int J Cancer 56: 255–261, 1994
18. Kitahara M, Katakura R, Suzuki J, Sasaki T: Experimental combination chemotherapy of ACNU and 5-FU against cultured glioma model (spheroid) and subcutaneous rat glioma. Int J Cancer 40: 557–563, 1987
19. Kolchinsky A, Roninson IB: Drug resistance conferred by MDR1 expression in spheroids formed by glioblastoma cell lines. Anticancer Res 17: 3321–3327, 1997
20. Fehlauer F, Muench M, Richter E, Rades D: The inhibition of proliferation and migration of glioma spheroids exposed to temozolomide is less than additive if combined with irradiation. Oncol Rep 17: 941–945, 2007
21. Shweiki D, Neeman M, Itin A, Keshet E: Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci USA 92: 768–772, 1995
22. Goldbrunner RH, Wagner S, Roosen K, Tonn JC: Models for assessment of angiogenesis in gliomas. J Neurooncol 50: 53–62, 2000
23. Tunici P, Bissola L, Lualdi E, Pollo B, Cajola L, Broggi G, Sozzi G, Finocchiaro G: Genetic alterations and in vivo tumorigenicity of neurospheres derived from an adult glioblastoma. Mol Cancer 3: 25, 2004
24. Chong YK, Toh TB, Zaiden N, Poonepalli A, Leong SH, Ong CE, Yu Y, Tan PB, See SJ, Ng WH, Ng I, Hande MP, Kon OL, Ang BT, Tang C: Cryopreservation of neurospheres derived from human glioblastoma multiforme. Stem Cells 27: 29–39, 2009
25. Yu SC, Ping YF, Yi L, Zhou ZH, Chen JH, Yao XH, Gao L, Wang JM, Bian XW: Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett 265: 124–134, 2008
26. Kumanishi T, Ikuta F, Yamamoto T: Brain tumors induced by Rous sarcoma virus, Schmidt-Ruppin strain. 3. Morphology of brain tumors induced in adult mice. J Natl Cancer Inst 50: 95–109, 1973
27. Gritti A, Frölichsthal-Schoeller P, Galli R, Parati EA, Cova L, Pagano SF, Bjornson CR, Vescovi AL: Epidermal and fibroblast growth factors behave as mitogenic regulators for a single multipotent stem cell-like population from the subventricular region of the adult mouse forebrain. J Neurosci 19: 3287–3297, 1999
28. Svendsen CN, Caldwell MA, Ostenfeld T: Human neural stem cells: isolation, expansion and transplantation. Brain Pathol 9: 499–513, 1999
29. Glimelius B, Norling B, Nederman T, Carlsson J: Extracellular matrices in multicellular spheroids of human glioma origin: increased incorporation of proteoglycans and fibronectin as compared to monolayer cultures. APMIS 96: 433–444, 1988
30. Deryugina EI, Bourdon MA: Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin. J Cell Sci 109 (Pt 3): 643–652, 1996
31. Joo KM, Kim SY, Jin X, Song SY, Kong DS, Lee JI, Jeon JW, Kim MH, Kang BG, Jung Y, Jin J, Hong SC, Park WY, Lee DS, Kim H, Nam DH: Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest 88: 808–815, 2008
32. Nishide K, Nakatani Y, Kiyonari H, Kondo T: Glioblastoma formation from cell population depleted of Prominin1-expressing cells. PLoS One 4: e6869, 2009
33. Clément V, Dutoit V, Marino D, Dietrich PY, Radovanovic I: Limits of CD133 as a marker of glioma self-renewing cells. Int J Cancer 125: 244–248, 2009
34. Fine HA: Glioma stem cells: not all created equal. Cancer Cell 15: 247–249, 2009
35. Ogden AT, Waziri AE, Lochhead RA, Fusco D, Lopez K, Ellis JA, Kang J, Assanah M, McKhann GM, Sisti MB, McCormick PC, Canoll P, Bruce JN: Identification of A2B5+CD133tumor-initiating cells in adult human gliomas. Neurosurgery 62: 505–514; discussion 514–515, 2008
36. Sun Y, Kong W, Falk A, Hu J, Zhou L, Pollard S, Smith A: CD133 (Prominin) negative human neural stem cells are clonogenic and tripotent. PLoS ONE 4: e5498, 2009
37. Jiang Y, Boije M, Westermark B, Uhrbom L: PDGF-B Can sustain self-renewal and tumorigenicity of experimental glioma-derived cancer-initiating cells by preventing oligodendrocyte differentiation. Neoplasia 13: 492–503, 2011
38. Persson AI, Petritsch C, Swartling FJ, Itsara M,Sim FJ, Auvergne R, Goldenberg DD, Vandenberg SR, Nguyen KN, Yakovenko S, Ayers-Ringler J, Nishiyama A, Stallcup WB, Berger MS, Bergers G, McKnight TR, Goldman SA, Weiss WA: Non-stem cell origin for oligodendroglioma. Cancer Cell 18: 669–682, 2010
39. Tonn JC, Haugland HK, Saraste J, Roosen K, Laerum OD: Differential effects of vincristine and phenytoin on the proliferation, migration, and invasion of human glioma cell lines. J Neurosurg 82: 1035–1043, 1995
40. Vajkoczy P, Goldbrunner R, Farhadi M, Vince G, Schilling L, Tonn JC, Schmiedek P, Menger MD: Glioma cell migration is associated with gliomainduced angiogenesis in vivo. Int J Dev Neurosci 17: 557–563, 1999
41. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, Small JE, Herrlinger U, Ourednik V, Black PM, Breakefield XO, Snyder EY: Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 97: 12846–12851, 2000
42. Tang Y, Shah K, Messerli SM, Snyder E, Breakefield X, Weissleder R: In vivo tracking of neural progenitor cell migration to glioblastomas. Hum Gene Ther 14: 1247–1254, 2003
43. Goldman SA: Adult neurogenesis: from canaries to the clinic. J Neurobiol 36: 267–286, 1998
44. Ariza A, López D, Mate JL, Isamat M, Musulén E, Pujol M, Ley A, Navas-Palacios JJ: Role of CD44 in the invasiveness of glioblastoma multiforme and the noninvasiveness of meningioma: an immunohistochemistry study. Hum Pathol 26: 1144–1147, 1995
45. Levicar N, Dewey RA, Daley E, Bates TE, Davies D, Kos J, Pilkington GJ, Lah TT: Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis. Cancer Gene Ther 10: 141–151, 2003
46. Nakada M, Niska JA, Tran NL, McDonough WS, Berens ME: EphB2/R-Ras signaling regulates glioma cell adhesion, growth, and invasion. Am J Pathol 167: 565–576, 2005
47. Yamamoto S, Wakimoto H, Aoyagi M, Hirakawa K, Hamada H: Modulation of motility and proliferation of glioma cells by hepatocyte growth factor. Jpn J Cancer Res 88: 564–577, 1997
48. Xie Q, Gao CF, Shinomiya N, Sausville E, Hay R, Gustafson M, Shen Y, Wenkert D, Vande Woude GF: Geldanamycins exquisitely inhibit HGF/SF-mediatedtumor cell invasion. Oncogene 224: 3697–3707, 2005
49. Chintala SK, Sawaya R, Gokaslan ZL, Rao JS: Modulation of matrix metalloprotease-2 and invasion in human glioma cells by alpha 3 beta 1 integrin. Cancer Lett 103: 201–208, 1996
50. Thorns V, Walter GF, Thorns C: Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas. Anticancer Res 23: 3937–3944, 2003
51. Eckerich C, Zapf S, Fillbrandt R, Loges S, Westphal M, Lamszus K: Hypoxia can induce c-Met expression in glioma cells and enhance SF/HGF-induced cell migration. Int J Cancer 121: 276–283, 2007
52. Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, Lu L, Irvin D, Black KL, Yu JS: Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 5: 67, 2006
53. Jung S, Paek YW, Moon KS, Wee SC, Ryu HH, Jeong YI, Sun HS, Jin YH, Kim KK, Ahn KY: Expression of Nm23 in gliomas and its effect on migration and invasion in vitro. Anticancer Res 26: 249–258, 2006
54. Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W: Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 61: 2744–2750, 2001